---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-091620"
form_type: "8-K"
ticker: "FULC"
cik: "0001680581"
company_name: "Fulcrum Therapeutics, Inc."
filed_at: "2023-04-05T23:59:59+00:00"
generated_at: "2026-06-17T05:54:03.609216+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Fulcrum Therapeutics CFO Esther Rajavelu resigns effective April 21, 2023

## Summary
- CFO Esther Rajavelu resigns effective April 21, 2023 to pursue another opportunity.
- Company will conduct an executive search for a new chief financial officer.
- Rajavelu enters consulting agreement for up to 3 months; receives $52,780/month plus $6,000 initiation fee.
- Vested stock option exercise period extended to 12 months after consulting services end.

## SEC filing metadata
- accession: 0001193125-23-091620
- form_type: 8-K
- ticker: FULC
- cik: 0001680581
- company_name: Fulcrum Therapeutics, Inc.
- filed_at: 2023-04-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680581/000119312523091620/0001193125-23-091620-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680581/000119312523091620/d471861d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-091620
- JSON: https://secwatch.observer/filing/0001193125-23-091620.json
- Plain text: https://secwatch.observer/filing/0001193125-23-091620.txt

## Key facts
- Executive change
  Esther Rajavelu resigned as Chief Financial Officer at Fulcrum Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On March 31, 2023, Esther Rajavelu notified Fulcrum Therapeutics, Inc., or Fulcrum, of her intent to resign as chief financial officer and treasurer (and as principal financial officer), effective April 21, 2023, to pursue another opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1680581/000119312523091620/0001193125-23-091620-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.